Print

Karo Bio AB: Year-End Report January-December 2012  
2/12/2013 6:16:29 AM

Regulatory News:

Karo Bio: (STO:KARO)

The January–December period and the fourth quarter 2012 in brief

• Net sales increased to MSEK 33.2 (0.0), whereof the fourth quarter increased to MSEK 8.6 (0.0), mainly attributed to the RoRgamma deal with Pfizer

//-->